Literature DB >> 7690370

Expression of decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 in the human astroglioma cell line, D54-MG, and primary rat astrocytes.

C Yang1, J L Jones, S R Barnum.   

Abstract

In this report, we have shown the expression of the complement regulatory proteins decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 on human D54-MG astroglioma cells by several methods, including immunofluorescence, flow cytometry and Western blotting and Northern blot analysis. These studies demonstrate that all three proteins are structurally and antigenically similar to their counterparts expressed on HepG2 and SW480 cells (hepatocyte and epithelial cell lines, respectively). D54-MG cells express mRNA for all three proteins of the appropriate size(s). The phosphatidylinositol-specific enzyme, PIPLC, cleaved DAF from the surface of D54-MG cells, demonstrating that DAF is linked by a glycophospholipid anchor as has been shown for other cell types. Flow cytometry demonstrates that primary rat astrocytes also constitutively express all three regulatory proteins. These data are the first to demonstrate the expression of CD59 on astrocytes, and the presence of all three regulatory proteins on astrocytes suggests that regulation of complement activation in the central nervous system is important in neural host defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690370     DOI: 10.1016/0165-5728(93)90022-q

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Authors:  O B Spiller; O Criado-García; S Rodríguez De Córdoba; B P Morgan
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Authors:  Philippe Gasque; Jim W Neal; Sim K Singhrao; Eamon P McGreal; Yann D Dean; Beek Johan Van; B Paul Morgan
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

3.  CD55 expression patterns on intestinal neuronal tissue are divergent from the brain.

Authors:  K A Gelderman; H J M A A Zijlmans; M J Vonk; A Gorter
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 4.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

5.  Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes.

Authors:  P M Faustmann; D Krause; R Dux; R Dermietzel
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Expression and function of membrane regulators of complement on rat astrocytes in culture.

Authors:  C A Rogers; P Gasque; S J Piddlesden; N Okada; V M Holers; B P Morgan
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

7.  Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.

Authors:  Julien Ratelade; Hua Zhang; Samira Saadoun; Jeffrey L Bennett; Marios C Papadopoulos; A S Verkman
Journal:  Acta Neuropathol       Date:  2012-04-22       Impact factor: 17.088

8.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

9.  The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review.

Authors:  M R Griffiths; P Gasque; J W Neal
Journal:  Int J Inflam       Date:  2010-08-09

10.  Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs.

Authors:  Masato Hosokawa; Andis Klegeris; Patrick L McGeer
Journal:  J Neuroinflammation       Date:  2004-08-24       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.